Prominent Computer-Aided Drug Discovery Market Trend for 2025: Innovative AI-Driven Approaches Transforming Drug Discovery Enhancing Precision, Speed, And Efficiency

What Are the Projected Growth and Market Size Trends for the Computer-Aided Drug Discovery Market?_x000D_
Over the past few years, the market size for computer-aided drug discovery has seen substantial growth. The market valuation will rise from $6.69 billion in 2024 to $7.56 billion in 2025, marking a compound annual growth rate (CAGR) of 12.9%. The historical growth trend aligns with an improvement in computational power, advancements in molecular modeling, rising demand from the pharmaceutical sector, encouragement from regulatory bodies, and partnerships._x000D_
_x000D_
In the coming years, the market size of computer-aided drug discovery is predicted to experience rapid growth. By 2029, it is projected to reach a value of $12.19 billion, with a compound annual growth rate (CAGR) of 12.7%. The predicted growth during the forecast period can be linked to the integration of AI and ML in drug discovery procedures, a shift towards personalization in medicine, an increase in accessibility to large data volumes, and the creation and use of CADD based on cloud platforms for the development of new therapeutics. Notable trends during this forecast period include collaborations among various stakeholders, the expansion of AI-based platforms providing comprehensive solutions, advancements in drug discovery, and product innovations._x000D_
_x000D_
What Is Driving the Growth Trajectory of the Computer-Aided Drug Discovery Market?_x000D_
The surge in cancer cases is predicted to drive the expansion of the computer-aided drug discovery market in the future. Cancer, a collection of diseases marked by unregulated growth and division of abnormal cells, has seen an increase due to various factors such as alterations in lifestyle and urbanization, environmental pollution, consumption of tobacco and alcohol, healthcare accessibility, and increased awareness. The utilization of computer-aided drug discovery can assist in creating medications that target cancer cells harboring specific genetic mutations, providing a pathway towards more targeted and potent cancer treatments. For example, in May 2024, the National Cancer Institute, a US-based cancer research and training organization, reported nearly 20 million new instances and 9.7 million cancer-related mortality rates in 2022. These numbers are expected to rise dramatically by 2040, with an estimated 29.9 million new instances and 15.3 million fatalities annually. As a result, the hike in cancer cases is fueling the growth of the computer-aided drug discovery market._x000D_
_x000D_
Get Your Free Sample Now - Explore Exclusive Market Insights:_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=19379&type=smp_x000D_
_x000D_
Which Leading Companies Are Shaping the Growth of the Computer-Aided Drug Discovery Market?_x000D_
Major companies operating in the computer-aided drug discovery market are Dassault Systèmes SE, PerkinElmer Inc., Roivant Sciences Ltd., Certara Inc., Schrödinger Inc., XtalPi Inc., Dotmatics Limited, Simulations Plus Inc., ChemAxon Ltd., Exscientia Ltd., Insilico Medicine Inc., Collaborative Drug Discovery Inc., OpenEye Scientific Software Inc., Nimbus Therapeutics LLC, Atomwise Inc., GNS Healthcare Inc., BenevolentAI Limited, EpiVax Inc., Numerate Inc., Cloud Pharmaceuticals Inc., Aris Pharmaceuticals Inc., Cyclica Inc., BioSolveIT GmbH, Chemical Computing Group ULC, InSilicoTrials Technologies S.p.A_x000D_
_x000D_
What Are the Major Trends Shaping the Computer-Aided Drug Discovery Market?_x000D_
Major players in the computer-aided drug discovery (CADD) market are pioneering inventive strategies like artificial intelligence in drug discovery to amplify accuracy, hasten identification of prospective drug candidates, improve lead compounds, and aid in delivering personalized medicine. Applying AI technologies such as deep learning and machine learning, artificial intelligence (AI) in drug discovery uses superior algorithms making the discovery and creation of new drugs quicker, more economical, and more accurate. For instance, in December 2023, Merck KGaA, hailing from Germany and specializing in science and technology, inaugurated AIDDISONTM, the first-of-its-kind software-as-a-service platform merging drug discovery and synthesis. This platform amalgamates generative AI, machine learning, and computer-aided drug designing and accelerates drug development by virtually screening compounds from more than 60 billion chemical targets and suggesting the best synthesis routes. It utilizes two decades of pharmaceutical R&D data to pinpoint drug-like candidates that exhibit properties such as non-toxicity and stability. With the integration of Merck's SynthiaTM retrosynthesis API, AIDDISONTM optimizes drug production for efficiency and sustainability, with a goal to lessen the cost and the duration of drug discovery._x000D_
_x000D_
What Are the Key Segments of the Computer-Aided Drug Discovery Market?_x000D_
The computer-aided drug discoverymarket covered in this report is segmented -_x000D_
_x000D_
1) By Type: Structure Based Drug Design, Ligand-Based Drug Design, Sequence-Based Approaches_x000D_
2) By Therapeutic Area: Oncology, Neurology, Cardiovascular Disease, Respiratory Disease, Diabetes, Other Therapeutic Areas_x000D_
3) By End User: Pharmaceutical Companies, Biotechnology Companies, Research Laboratories_x000D_
_x000D_
Subsegments:_x000D_
1) By Structure Based Drug Design: X-ray Crystallography, Nuclear Magnetic Resonance (NMR) Spectroscopy, Molecular Docking Studies, Virtual Screening_x000D_
2) By Ligand-Based Drug Design: Quantitative Structure-Activity Relationship (QSAR) Models, Pharmacophore Modeling, Ligand Similarity Searching, Fragment-Based Drug Design_x000D_
3) By Sequence-Based Approaches: Protein Structure Prediction, Homology Modeling, Bioinformatics for Drug Target Identification, Genomic Data Analysis for Drug Discovery_x000D_
_x000D_
Pre-Book Your Report Now For A Swift Delivery:_x000D_
https://www.thebusinessresearchcompany.com/report/computer-aided-drug-discovery-global-market-report_x000D_
_x000D_
Which Region Dominates the Computer-Aided Drug Discovery Market?_x000D_
North America was the largest region in the computer-aided drug discovery (CADD) market in 2024. The regions covered in the computer-aided drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
What Is Covered In The Computer-Aided Drug Discovery Global Market Report?_x000D_
_x000D_
- Market Size Analysis: Analyze the Computer-Aided Drug Discovery Market size by key regions, countries, product types, and applications._x000D_
- Market Segmentation Analysis: Identify various subsegments within the Computer-Aided Drug Discovery Market for effective categorization._x000D_
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape._x000D_
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market._x000D_
- Market Contribution: Evaluate contributions of different segments to the overall Computer-Aided Drug Discovery Market growth._x000D_
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers._x000D_
- Industry Challenges: Analyze challenges and risks affecting the Computer-Aided Drug Discovery Market._x000D_
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market._x000D_
_x000D_
Unlock Exclusive Market Insights - Purchase Your Research Report Now!_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19379

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.